Detalles de la búsqueda
1.
Results from a phase I/II trial of cusatuzumab combined with azacitidine in patients with newly diagnosed acute myeloid leukemia who are ineligible for intensive chemotherapy.
Haematologica
; 108(7): 1793-1802, 2023 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36779592
2.
Feasibility of electronic patient-reported outcome monitoring and self-management program in aplastic anemia and paroxysmal nocturnal hemoglobinuria-a pilot study (ePRO-AA-PNH).
Ann Hematol
; 102(1): 199-208, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36326854
3.
Late effects of high-dose methotrexate treatment in childhood cancer survivors-a systematic review.
BMC Cancer
; 22(1): 267, 2022 Mar 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-35287628
4.
Short regimen of rituximab plus lenalidomide in follicular lymphoma patients in need of first-line therapy.
Blood
; 134(4): 353-362, 2019 07 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-31101627
5.
Effects of lenalidomide on the bone marrow microenvironment in acute myeloid leukemia: Translational analysis of the HOVON103 AML/SAKK30/10 Swiss trial cohort.
Ann Hematol
; 100(5): 1169-1179, 2021 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-33704530
6.
Prognostic models integrating quantitative parameters from baseline and interim positron emission computed tomography in patients with diffuse large B-cell lymphoma: post-hoc analysis from the SAKK38/07 clinical trial.
Hematol Oncol
; 38(5): 715-725, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-32947651
7.
A new protocol for improving efficiency of autologous peripheral blood stem cell collection in patients with high white blood cell counts.
J Clin Apher
; 35(3): 217-223, 2020 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-32304598
8.
The sympathomimetic agonist mirabegron did not lower JAK2-V617F allele burden, but restored nestin-positive cells and reduced reticulin fibrosis in patients with myeloproliferative neoplasms: results of phase II study SAKK 33/14.
Haematologica
; 104(4): 710-716, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30409796
9.
DNMT3A mutation is associated with increased age and adverse outcome in adult T-cell acute lymphoblastic leukemia.
Haematologica
; 104(8): 1617-1625, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-30655366
10.
Mobilization of Hematopoietic Progenitor Cells with Standard- or Reduced-Dose Filgrastim after Vinorelbine in Multiple Myeloma Patients: A Randomized Prospective Single-Center Phase II Study.
Biol Blood Marrow Transplant
; 24(4): 694-699, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29246820
11.
Bendamustine, lenalidomide and dexamethasone (BRd) has high activity as 2nd -line therapy for relapsed and refractory multiple myeloma - a phase II trial.
Br J Haematol
; 176(5): 770-782, 2017 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-27983764
12.
Y90 -Ibritumomab tiuxetan (Y90 -IT) and high-dose melphalan as conditioning regimen before autologous stem cell transplantation for elderly patients with lymphoma in relapse or resistant to chemotherapy: a feasibility trial (SAKK 37/05).
Hematol Oncol
; 35(4): 576-583, 2017 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-27677906
13.
Efficacious and save use of biosimilar filgrastim for hematopoietic progenitor cell chemo-mobilization with vinorelbine in multiple myeloma patients.
J Clin Apher
; 32(1): 21-26, 2017 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-27001243
14.
PAX5 P80R mutation identifies a novel subtype of B-cell precursor acute lymphoblastic leukemia with favorable outcome.
Blood
; 133(3): 280-284, 2019 01 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-30510083
15.
Association of Nutritional Parameters with Clinical Outcomes in Patients with Acute Myeloid Leukemia Undergoing Haematopoietic Stem Cell Transplantation.
Ann Nutr Metab
; 69(2): 89-98, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27639391
16.
Efficacy of vinorelbine plus granulocyte colony-stimulation factor for CD34+ hematopoietic progenitor cell mobilization in patients with multiple myeloma.
Biol Blood Marrow Transplant
; 21(1): 74-80, 2015 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-25278456
17.
A degradation-sensitive anionic trypsinogen (PRSS2) variant protects against chronic pancreatitis.
Nat Genet
; 38(6): 668-73, 2006 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-16699518
18.
Favorable effect of priming with granulocyte colony-stimulating factor in remission induction of acute myeloid leukemia restricted to dose escalation of cytarabine.
Blood
; 119(23): 5367-73, 2012 Jun 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-22422824
19.
Autologous peripheral blood stem cell transplantation for acute myeloid leukemia.
Blood
; 118(23): 6037-42, 2011 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-21951683
20.
Higher emotional distress in female partners of cancer patients: prevalence and patient-partner interdependencies in a 3-year cohort.
Psychooncology
; 22(12): 2693-701, 2013 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-23825026